Fundraising Fox

Lycia Therapeutics

South San Francisco, US · Founded 2019 · Delaware corporation · 9 known investors

Biotech

Founders & leadership

TA
Tim AndersonDirector
WR
William RieflinDirector
AW
Aetna Wun TrombleyExecutive Officer, Director
LF
Laurent FischerDirector
MF
Ming FangDirector
AB
Amy BachrodtExecutive Officer
TW
Thomas WoiwodeDirector
JS
Jeremy S. CaldwellExecutive Officer, Director
CO
Clare OzawaDirector

Investors · 9

BAM ElevatereportedChicago
Franklin TempletonreportedLondon
HBM Healthcare InvestmentsreportedZug
Janus Henderson InvestorsreportedNew York
OrbiMedreportedNew York · $1M – $75M
RTW Investments L.P.reportedNew York
Venrock Healthcare Capital PartnersreportedNew York
Versant Venture CapitalreportedSan Francisco
Versant VenturesreportedSan Francisco · $250K – $5Mvia Clare Ozawa · board

Reported raises · per SEC filings

Form D private placements
▶$75MraisedJun 2026 · 16 investors · Biotechnology
Rule 506(b)
Lycia Therapeutics has filed a notice of an exempt offering of securities to raise $75 Million in New Funding. - intelligence360intelligence360.news · Jul 2026Lycia Therapeutics Raises $75M in Series D Fundingfinsmes.com · Jun 2026
Officers, directors & promoters on the filing
  • Tim AndersonDirector
  • William RieflinDirector
  • Clare OzawaDirector
  • Aetna Wun TrombleyExecutive Officer, Director
  • Laurent FischerDirector
  • Ming FangDirector
  • Amy BachrodtExecutive Officer
Offering amount
$75M
Amount sold
$75M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$106.6MraisedMay 2024 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ming FangDirector
  • Laurent FischerDirector
  • Tim AndersonDirector
  • Andrew GottesdienerDirector
  • William RieflinDirector
  • Clare OzawaDirector
  • Aetna Wun TrombleyExecutive Officer, Director
Offering amount
$106.6M
Amount sold
$106.6M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70.1MraisedSep 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laurent FischerDirector
  • William RieflinDirector
  • Clare OzawaDirector
  • Thomas WoiwodeDirector
  • Tim AndersonDirector
  • Aetna Wun TrombleyExecutive Officer, Director
Offering amount
$70.1M
Amount sold
$70.1M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.4MraisedMar 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clare OzawaDirector
  • Thomas WoiwodeDirector
  • Laurent FischerDirector
  • Jeremy S. CaldwellExecutive Officer, Director
Offering amount
$50.4M
Amount sold
$25.4M
Minimum investment
$1
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news